Meeting summary

Quick recap

This meeting focused on updates and discussions regarding substance use disorder treatment services and HHSC (Health and Human Services Commission) interactions. Noelle led the meeting in Doug's absence and provided updates on HHSC meetings, including discussions about OSARs contracts and the potential impact of GLP-1 medications on treatment approaches. The group discussed concerns about Medicaid rate increases, with Carrie sharing information about higher VA rates for residential treatment compared to current Medicaid rates. Participants also addressed issues with managed care organizations, procurement processes, and the disconnect between regulatory requirements and program implementation. The conversation ended with updates about upcoming HHSC rate evaluation meetings and the importance of providing feedback during the current sunset review process.

Next steps

• Carrie: Coordinate with public relations to send photos from the facility opening to Anna for newsletter and social media.

• Anna: Share the GLP-1 study with interested group members and/or…

A recent overview from Osmind highlights emerging evidence on GLP-1 receptor agonists (e.g., Ozempic, Wegovy) and their potential relevance in psychiatry and behavioral health.

Key Takeaways:

• Reduced substance use & cravings:Early studies suggest GLP-1 medications may reduce cravings for alcohol, nicotine, and possibly other substances—raising interest in their role for SUD treatment.

• Mental health effects (mixed but promising):Some patients report improvements in mood and compulsive behaviors, though data is still limited and not yet conclusive.

• Mechanism matters:These medications act on brain reward pathways (dopamine-related systems), which may explain effects on addiction and impulse control—not just appetite.

• Caution + monitoring needed:There are also reports of potential psychiatric side effects (e.g., mood changes, suicidal ideation), so careful screening and monitoring are essential.

Meeting summary

Quick recap

The meeting focused on discussing challenges with HHSC contracts, particularly around CCMS (Case Management Services) implementation and performance measures. Providers raised concerns about the 24-hour waiting period requirement and service termination rules, which were creating operational difficulties. The group also explored questions about Dr. Laguna's sphere of influence and how to effectively engage with HHSC leadership. There was significant discussion about private insurance billing challenges and the need to better understand and navigate Medicaid managed care systems. The conversation concluded with updates about upcoming changes to the billing structure and a reminder about the upcoming general membership meeting.

Next steps

• Anna: Ask Noelle to discuss or provide examples of appropriate topics and her purview for HHSC leadership meetings, potentially at the upcoming general membership meeting or next month's call.

• Anna: Share the previously distributed list of funded providers/contracts with the group again, and share in the…